Rhythm Pharmaceuticals In... (RYTM)
51.97
1.97 (3.94%)
At close: Apr 02, 2025, 3:59 PM
50.05
-3.69%
After-hours: Apr 02, 2025, 06:13 PM EDT
Rhythm Pharmaceuticals Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -260.6M | -184.68M | -181.12M | -69.61M | -134M | -140.73M | -74.06M | -33.71M | -25.87M | -11.07M | -6.49M | -21.43M | -18.13M |
| Depreciation & Amortization | 1.56M | 1.76M | 1.67M | 1.16M | 690K | 834K | 442K | 223K | 144K | n/a | n/a | 20K | 17K |
| Stock-Based Compensation | 39.68M | 32.55M | 19.83M | 20.8M | 17.45M | 11.88M | 6.39M | 2.28M | 1.17M | 298K | 66K | 127K | n/a |
| Other Working Capital | 2.42M | 4.38M | -13.26M | -15.15M | -16.4M | -5.44M | -6.29M | -1.99M | 863K | -1.46M | -801K | 2.78M | -1.38M |
| Other Non-Cash Items | 94.9M | 9.4M | 5.91M | -250K | -234K | 203K | 4.51M | -76K | 11K | 1.42M | -280K | 255K | 82K |
| Deferred Income Tax | n/a | n/a | n/a | -100M | n/a | n/a | n/a | 1.86M | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 10.57M | 4.81M | -19.72M | 1.9M | -5.89M | 5.07M | 667K | -39K | 1.33M | 2.38M | -801K | 2M | 201K |
| Operating Cash Flow | -113.88M | -136.16M | -173.43M | -146M | -121.98M | -122.75M | -62.06M | -29.46M | -23.22M | -6.98M | -7.51M | -19.16M | -17.83M |
| Capital Expenditures | n/a | -47K | -4.28M | -5.43M | -214K | -3.38M | -722K | -133K | -1.06M | -17K | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | 4M | 100M | -158.75M | 24.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -268.31M | -354.92M | -251.94M | -524.97M | -86.87M | -295.82M | -248.59M | -126.92M | -15.22M | n/a | n/a | -28.74M | -8.8M |
| Sales Maturities Of Investments | 260.64M | 354.97M | 284.25M | 361.25M | 245.61M | 271.24M | 162.17M | 17.01M | 11.17M | n/a | n/a | 23.61M | 3.53M |
| Other Investing Acitivies | -40.5M | -5.67M | -4M | 7M | 158.75M | -24.59M | -86.43M | -109.91M | -4.05M | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -48.17M | -5.67M | 28.03M | -62.16M | 158.53M | -27.97M | -87.15M | -110.04M | -5.11M | -17K | n/a | -5.13M | -5.27M |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | -3.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 195.21M | 25.49M | 82.72M | 4.75M | 2.01M | 2.12M | 1.81M | 700K | n/a | 2.09M | 7.42M | n/a | n/a |
| Financial Cash Flow | 191.24M | 74.37M | 213.83M | 166.48M | 2.01M | 163.47M | 164.69M | 167.2M | n/a | 41.71M | 7.42M | 19.88M | 22.44M |
| Net Cash Flow | 29.19M | -67.6M | 68.43M | -41.68M | 38.56M | 12.75M | 15.48M | 27.7M | -28.33M | 34.72M | -89K | -4.4M | -660K |
| Free Cash Flow | -113.88M | -136.2M | -177.71M | -151.44M | -122.19M | -126.14M | -62.78M | -29.59M | -24.28M | -6.99M | -7.51M | -19.16M | -17.83M |